MedTrace Logo

Bone Marrow Aspirate Concentrate (BMAC) Supplementation for Osteochondral Lesions

NCT02011295 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2019-08-16

No results posted yet for this study

Summary

The purpose of this study is to determine the clinical efficacy of the application of bone marrow aspirate concentrate (BMAC) as a supplement to microfracture in the treatment of osteochondral lesions of the talus (OLTs).

Conditions

  • Osteochondral Lesions of Talus

Interventions

PROCEDURE

ankle arthroscopy with debridement and microfracture of the OLT

ankle arthroscopy with debridement and microfracture of the OLT

OTHER

Bone Marrow Aspirate injection

Sponsors & Collaborators

Principal Investigators

  • Samuel B Adams, MD · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-29
Primary Completion
2019-06-26
Completion
2019-06-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02011295 on ClinicalTrials.gov